The EULAR recommendations for the management of rheumatoid arthritis ( RA ) support differential treatment between patients with baseline characteristics suggestive of a non-poor prognosis ( non-PP ) or poor prognosis ( PP ) ( presence of autoantibodies , a high inflammatory activity and damage on radiographs ) .